Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data

PURPOSE: Tobramycin inhalation powder (TIP), the first dry-powder inhaled antibiotic for pulmonary Pseudomonas aeruginosa infection, is associated with reduced treatment burden, increased patient satisfaction, and higher self-reported adherence for cystic fibrosis (CF) patients. We compared adherenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Kamal, Conti, Valentino, Tian, Hengfeng, Loefroth, Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414718/
https://www.ncbi.nlm.nih.gov/pubmed/28490864
http://dx.doi.org/10.2147/PPA.S134759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414718/
https://www.ncbi.nlm.nih.gov/pubmed/28490864
http://dx.doi.org/10.2147/PPA.S134759

Ejemplares similares